Top Vestd Alternatives in 2026

Ledgy is the alternative that looks and feels most like what a Vestd buyer already expects: a cap table platform built around European and UK equity rules instead of US 409A workflows. The Launch plan is free forever for up to 50 stakeholders, covering cap table management and equity plan automation with self-serve support, no sales call needed to get started. Ledgy has been actively marketing to companies leaving Carta over pricing, and reviewers cite it as easier to use and better value once you're past the free tier. The catch is that every paid plan, Scale, Enterprise, and Public, is a custom quote, so you'll still end up on a sales call once you outgrow the free tier's 50 stakeholders. There's no phone support or round-the-clock coverage either, which matters if your team works outside European hours.

Carta is the market's default cap table tool, and that familiarity is a real reason to consider it even if you don't love the switch. Most VCs, lawyers, and auditors already know how to read a Carta cap table, which can smooth diligence and 409A reviews. The Launch plan is genuinely free for companies under 25 stakeholders and $1M raised, and Carta acts as its own SEC-registered transfer agent for option exercises. Past the free tier, pricing is entirely quote-based, and multiple reviewers describe steep, unannounced renewal increases, in one case a jump from $99 to $3,000. If Vestd's UK-specific EMI and HMRC workflows are what you actually rely on, Carta's US-first structure doesn't replace them, so treat this as a name-recognition trade rather than a like-for-like swap.

Pulley was built as a direct answer to Carta's pricing complaints, and it shows: both paid tiers post real annual numbers on the pricing page instead of forcing a sales call. Startup is $1,200 a year for 25 stakeholders, and Growth is $3,500 a year for 40, with 409A valuations and option exercises included at that level rather than sold as pricey add-ons. Onboarding is concierge-assisted, and switching from Carta comes with a free trial using your migrated data. The tradeoffs are that there's no free plan, so even a small cap table costs money from day one, and once you pass 40 stakeholders you're pushed into a custom Enterprise quote just like the tools you were trying to avoid. It's a transparent, US-first equity platform, not a UK compliance specialist.

Cake Equity is the budget pick among these alternatives, with a free plan that covers up to 5 stakeholders on real cap table, option, and SAFE features, not a stripped demo. Build, at $1,000 a year, adds vesting, board approval, and fundraising modeling for up to 25 stakeholders, and Team, at $2,750 a year, bundles two audit-ready 409A valuations a year plus a My Cake portal where employees can see and exercise their own equity. Pricing scales with stakeholder count rather than charging per seat, which suits founder-heavy early cap tables. It gets more expensive fast once you're past the included headcount, at $5 per extra stakeholder on Team, and the top Pro tier is quote-only. It's a US-oriented equity tool, so it won't cover EMI or HMRC submissions the way Vestd does.

Eqvista pairs cap table software with 409A valuations done by its own NACVA-certified analysts, so the valuation report ties back into your cap table instead of arriving as a standalone PDF from a separate firm. The Premium Cap Table tier is $2 per stakeholder per month, one of the cheapest published per-seat rates in this set, and the 409A bundle starts at $990 a year for pre-revenue companies with unlimited updates and renewals included for the year. Support is email-only, though reviewers say response times are fast despite that. Pricing steps up by funding stage for the 409A bundle and goes custom past 50 stakeholders or Series B, and at least one reviewer reported being billed after cancelling. Like the other US-built options here, it doesn't cover UK EMI or CSOP schemes.

Mantle charges a flat annual fee per plan instead of pricing by stakeholder count, and its free Starter plan includes unlimited stakeholders rather than a capped trial, which is unusual in this category. Essentials, at $1,200 a year, adds e-signing and option exercising, and Growth, at $3,000 a year, bundles one 409A valuation a year plus VIP support. The pitch is straightforward: hiring more people or granting more equity shouldn't push you into a pricier tier, and Mantle's newest feature, Mantle Clerk, uses AI to read legal documents and draft the resulting cap table updates. It only bills annually, with no monthly option, and some reviewers note it's missing a stock-based compensation calculator that bigger platforms include. Like the other alternatives here, it's a US-built tool without Vestd's UK EMI or HMRC-specific workflows.